Pharmacodynamic Modeling and Exposure-Response Assessment of Inebilizumab in Subjects with Neuromyelitis Optica Spectrum Disorders

A hematopoietic transit model was developed to describe the joint effects of reducing influx from pro-B cells and accelerating CD20+ B cell depletion in the blood by inebilizumab.